Calcium in PDB 4btx: Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Enzymatic activity of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
All present enzymatic activity of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors:
1.4.3.21;
Protein crystallography data
The structure of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors, PDB code: 4btx
was solved by
E.Bligt-Linden,
M.Pihlavisto,
I.Szatmari,
Z.Otwinowski,
D.J.Smith,
L.Lazar,
F.Fulop,
T.A.Salminen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.05 /
2.78
|
Space group
|
P 65 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
226.350,
226.350,
217.226,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
18.065 /
23.679
|
Other elements in 4btx:
The structure of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
(pdb code 4btx). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 4 binding sites of Calcium where determined in the
Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors, PDB code: 4btx:
Jump to Calcium binding site number:
1;
2;
3;
4;
Calcium binding site 1 out
of 4 in 4btx
Go back to
Calcium Binding Sites List in 4btx
Calcium binding site 1 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca1763
b:33.4
occ:1.00
|
O
|
A:LEU530
|
2.1
|
26.2
|
1.0
|
OD1
|
A:ASP673
|
2.2
|
28.6
|
1.0
|
OD1
|
A:ASP531
|
2.3
|
27.2
|
1.0
|
O
|
A:LEU674
|
2.4
|
32.9
|
1.0
|
OD1
|
A:ASP529
|
2.5
|
23.9
|
1.0
|
N
|
A:LEU674
|
3.2
|
31.9
|
1.0
|
C
|
A:LEU530
|
3.3
|
27.3
|
1.0
|
C
|
A:LEU674
|
3.4
|
31.0
|
1.0
|
CG
|
A:ASP673
|
3.5
|
30.5
|
1.0
|
CG
|
A:ASP531
|
3.6
|
27.6
|
1.0
|
ND2
|
A:ASN537
|
3.6
|
36.1
|
1.0
|
CG
|
A:ASP529
|
3.8
|
24.0
|
1.0
|
CA
|
A:LEU674
|
3.8
|
31.2
|
1.0
|
C
|
A:ASP673
|
3.9
|
33.9
|
1.0
|
CA
|
A:ASP531
|
4.0
|
28.8
|
1.0
|
NZ
|
A:LYS106
|
4.0
|
37.2
|
1.0
|
N
|
A:ASP531
|
4.1
|
27.4
|
1.0
|
CA
|
A:ASP673
|
4.1
|
35.0
|
1.0
|
O
|
A:LEU535
|
4.1
|
33.0
|
1.0
|
OD2
|
A:ASP673
|
4.3
|
29.1
|
1.0
|
CB
|
A:ASP531
|
4.4
|
28.1
|
1.0
|
N
|
A:LEU530
|
4.4
|
27.4
|
1.0
|
CB
|
A:ASP673
|
4.4
|
33.2
|
1.0
|
OD2
|
A:ASP529
|
4.4
|
23.1
|
1.0
|
CA
|
A:LEU530
|
4.4
|
27.8
|
1.0
|
OD2
|
A:ASP531
|
4.5
|
25.5
|
1.0
|
C
|
A:ASP529
|
4.5
|
25.4
|
1.0
|
N
|
A:VAL675
|
4.6
|
29.3
|
1.0
|
CB
|
A:LEU674
|
4.6
|
29.9
|
1.0
|
CA
|
A:ASP529
|
4.8
|
25.0
|
1.0
|
O
|
A:ASP673
|
4.9
|
33.3
|
1.0
|
O
|
A:ASP529
|
4.9
|
23.4
|
1.0
|
CB
|
A:ASP529
|
4.9
|
24.7
|
1.0
|
CG
|
A:ASN537
|
4.9
|
35.2
|
1.0
|
|
Calcium binding site 2 out
of 4 in 4btx
Go back to
Calcium Binding Sites List in 4btx
Calcium binding site 2 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca1764
b:46.3
occ:1.00
|
OE1
|
A:GLU667
|
2.4
|
57.2
|
1.0
|
O
|
A:PHE663
|
2.4
|
38.7
|
1.0
|
OD1
|
A:ASN665
|
2.5
|
47.5
|
1.0
|
OE2
|
A:GLU572
|
2.6
|
34.9
|
1.0
|
OE1
|
A:GLU572
|
3.1
|
38.3
|
1.0
|
CD
|
A:GLU572
|
3.2
|
38.9
|
1.0
|
CG
|
A:ASN665
|
3.4
|
52.0
|
1.0
|
CD
|
A:GLU667
|
3.4
|
52.4
|
1.0
|
C
|
A:PHE663
|
3.4
|
36.0
|
1.0
|
NZ
|
A:LYS638
|
3.7
|
39.1
|
1.0
|
ND2
|
A:ASN665
|
3.7
|
55.6
|
1.0
|
OE1
|
A:GLU641
|
3.7
|
37.1
|
1.0
|
OE2
|
A:GLU641
|
3.9
|
37.3
|
1.0
|
CA
|
A:PHE663
|
3.9
|
32.2
|
1.0
|
OE2
|
A:GLU667
|
4.0
|
46.0
|
1.0
|
CG2
|
A:THR635
|
4.1
|
44.8
|
1.0
|
CD
|
A:GLU641
|
4.2
|
35.7
|
1.0
|
OG1
|
A:THR635
|
4.4
|
43.3
|
1.0
|
CE
|
A:LYS638
|
4.4
|
36.7
|
1.0
|
CG
|
A:GLU667
|
4.5
|
50.3
|
1.0
|
O
|
A:GLN636
|
4.5
|
32.4
|
1.0
|
N
|
A:ILE664
|
4.6
|
39.3
|
1.0
|
CB
|
A:PHE663
|
4.6
|
30.2
|
1.0
|
CB
|
A:ASN665
|
4.7
|
48.7
|
1.0
|
CB
|
A:GLN636
|
4.7
|
34.9
|
1.0
|
N
|
A:GLN636
|
4.7
|
35.4
|
1.0
|
CG
|
A:GLU572
|
4.8
|
39.0
|
1.0
|
N
|
A:ASN665
|
4.8
|
42.6
|
1.0
|
O
|
A:ASP662
|
4.8
|
37.0
|
1.0
|
CB
|
A:THR635
|
4.8
|
41.4
|
1.0
|
CD
|
A:LYS638
|
4.9
|
34.5
|
1.0
|
CA
|
A:ILE664
|
5.0
|
37.3
|
1.0
|
|
Calcium binding site 3 out
of 4 in 4btx
Go back to
Calcium Binding Sites List in 4btx
Calcium binding site 3 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca1763
b:30.1
occ:1.00
|
O
|
B:HOH2100
|
2.1
|
17.3
|
1.0
|
OD1
|
B:ASP529
|
2.1
|
29.6
|
1.0
|
O
|
B:LEU674
|
2.3
|
28.1
|
1.0
|
OD1
|
B:ASP531
|
2.4
|
28.5
|
1.0
|
OD1
|
B:ASP673
|
2.5
|
28.2
|
1.0
|
O
|
B:LEU530
|
2.7
|
37.3
|
1.0
|
CG
|
B:ASP529
|
3.2
|
33.6
|
1.0
|
NZ
|
B:LYS106
|
3.3
|
26.4
|
1.0
|
C
|
B:LEU530
|
3.4
|
34.7
|
1.0
|
C
|
B:LEU674
|
3.5
|
27.9
|
1.0
|
CG
|
B:ASP531
|
3.6
|
29.9
|
1.0
|
CG
|
B:ASP673
|
3.7
|
27.6
|
1.0
|
C
|
B:ASP529
|
3.8
|
30.8
|
1.0
|
N
|
B:LEU530
|
3.9
|
30.8
|
1.0
|
N
|
B:LEU674
|
3.9
|
28.7
|
1.0
|
OD2
|
B:ASP529
|
4.0
|
34.5
|
1.0
|
CA
|
B:ASP529
|
4.0
|
31.5
|
1.0
|
N
|
B:ASP531
|
4.0
|
34.1
|
1.0
|
O
|
B:ASP529
|
4.0
|
28.1
|
1.0
|
CB
|
B:ASP529
|
4.2
|
33.2
|
1.0
|
OD2
|
B:ASP673
|
4.3
|
25.5
|
1.0
|
CA
|
B:LEU530
|
4.3
|
33.2
|
1.0
|
CA
|
B:ASP531
|
4.3
|
31.7
|
1.0
|
CA
|
B:LEU674
|
4.3
|
27.8
|
1.0
|
OD2
|
B:ASP531
|
4.4
|
28.7
|
1.0
|
C
|
B:ASP673
|
4.4
|
28.6
|
1.0
|
N
|
B:VAL675
|
4.5
|
26.7
|
1.0
|
CB
|
B:ASP531
|
4.6
|
30.9
|
1.0
|
CA
|
B:VAL675
|
4.6
|
27.1
|
1.0
|
ND2
|
B:ASN537
|
4.7
|
38.6
|
1.0
|
CE
|
B:LYS106
|
4.8
|
26.2
|
1.0
|
CA
|
B:ASP673
|
4.8
|
28.4
|
1.0
|
CB
|
B:ASP673
|
4.9
|
27.7
|
1.0
|
O
|
B:ASP673
|
4.9
|
29.7
|
1.0
|
CB
|
B:VAL675
|
5.0
|
26.6
|
1.0
|
|
Calcium binding site 4 out
of 4 in 4btx
Go back to
Calcium Binding Sites List in 4btx
Calcium binding site 4 out
of 4 in the Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Crystal Structure of Human Vascular Adhesion Protein-1 in Complex with Pyridazinone Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca1764
b:40.6
occ:1.00
|
O
|
B:PHE663
|
2.2
|
34.7
|
1.0
|
OE1
|
B:GLU667
|
2.2
|
43.2
|
1.0
|
O
|
B:HOH2108
|
2.4
|
29.3
|
1.0
|
OE2
|
B:GLU572
|
2.8
|
31.9
|
1.0
|
OE1
|
B:GLU572
|
2.8
|
28.4
|
1.0
|
OD1
|
B:ASN665
|
2.9
|
45.6
|
1.0
|
CD
|
B:GLU572
|
3.2
|
32.0
|
1.0
|
CD
|
B:GLU667
|
3.2
|
37.9
|
1.0
|
C
|
B:PHE663
|
3.3
|
33.5
|
1.0
|
CG
|
B:ASN665
|
3.4
|
44.0
|
1.0
|
ND2
|
B:ASN665
|
3.5
|
45.0
|
1.0
|
NZ
|
B:LYS638
|
3.6
|
35.1
|
1.0
|
OE2
|
B:GLU641
|
3.8
|
30.5
|
1.0
|
OE2
|
B:GLU667
|
3.9
|
36.7
|
1.0
|
CA
|
B:PHE663
|
4.0
|
33.6
|
1.0
|
OE1
|
B:GLU641
|
4.2
|
33.9
|
1.0
|
CG
|
B:GLU667
|
4.2
|
36.5
|
1.0
|
N
|
B:ASN665
|
4.4
|
44.3
|
1.0
|
N
|
B:ILE664
|
4.4
|
33.7
|
1.0
|
CD
|
B:GLU641
|
4.4
|
31.3
|
1.0
|
CA
|
B:ILE664
|
4.6
|
36.8
|
1.0
|
CB
|
B:ASN665
|
4.6
|
42.7
|
1.0
|
O
|
B:ASP662
|
4.7
|
44.2
|
1.0
|
CG
|
B:GLU572
|
4.7
|
32.3
|
1.0
|
CB
|
B:PHE663
|
4.7
|
31.6
|
1.0
|
CD
|
B:LYS638
|
4.7
|
33.2
|
1.0
|
CB
|
B:GLU667
|
4.8
|
37.4
|
1.0
|
CE
|
B:LYS638
|
4.8
|
34.4
|
1.0
|
C
|
B:ILE664
|
4.9
|
40.5
|
1.0
|
N
|
B:GLN636
|
4.9
|
32.5
|
1.0
|
CG2
|
B:THR635
|
4.9
|
27.0
|
1.0
|
OG1
|
B:THR635
|
4.9
|
27.8
|
1.0
|
|
Reference:
E.Bligt-Linden,
M.Pihlavisto,
I.Szatmari,
Z.Otwinowski,
D.J.Smith,
L.Lazar,
F.Fulop,
T.A.Salminen.
Novel Pyridazinone Inhibitors For Vascular Adhesion Protein- 1 (Vap-1): Old Target - New Inhibition Mode. J.Med.Chem. V. 56 9837 2013.
ISSN: ISSN 0022-2623
PubMed: 24304424
DOI: 10.1021/JM401372D
Page generated: Sat Jul 13 22:50:14 2024
|